MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 189 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2021. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,003,000 | -36.5% | 76,312 | -54.8% | 0.02% | -31.8% |
Q4 2020 | $3,154,000 | +51.1% | 168,800 | +37.3% | 0.02% | +57.1% |
Q3 2020 | $2,087,000 | +9.8% | 122,900 | +50.6% | 0.01% | -6.7% |
Q2 2020 | $1,900,000 | +992.0% | 81,600 | +292.3% | 0.02% | +650.0% |
Q1 2020 | $174,000 | -51.1% | 20,800 | -43.0% | 0.00% | 0.0% |
Q4 2019 | $356,000 | -34.9% | 36,491 | -36.7% | 0.00% | -33.3% |
Q3 2019 | $547,000 | -37.8% | 57,691 | -22.0% | 0.00% | -50.0% |
Q2 2019 | $879,000 | +97.1% | 73,991 | +135.6% | 0.01% | +100.0% |
Q1 2018 | $446,000 | – | 31,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |